Cyclerion Therapeutics Inc (CYCN) Annual Balance Sheets

Annual · GAAP · USD millions
Access CYCN quarterly Balance Sheets →
The balance sheet data below highlights changes in Cyclerion Therapeutics Inc's financial position over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent3.24
Cash & Short-term Investments3.00
Accounts receivable1.00
Other Current Assets0.01
Prepaid Expense, Current AS0.38
Total Current Assets4.64
Equipment/Property/Plant Net0.00
Long-term investments5.35
Other Assets, Noncurrent5.35
Operating Lease Right Of Use Asset-
Total Assets9.99
Liabilities
Accounts Payable, Current AC0.51
Other Liabilities, Current0.39
Total Current Liabilities0.90
Total Long-term Debt0.00
Accrued Expenses And Other Liabilities Current0.19
Total Liabilities0.90
Stockholders' Equity
Additional Paid In Capital Common Stock280.11
Retained Earnings / Accumulated Deficit-271.02
Other Equity0.00
Common Stockholder's Equity9.09
Total Stockholder's Equity9.09
Liabilities & Stockholder's Equity9.99
4 historic quarters locked

Sign in to unlock the full Cyclerion Therapeutics Inc balance sheet history.

About Cyclerion Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-132193

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License